Related references
Note: Only part of the references are listed.CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer
Joerg Ellinger et al.
UROLOGY (2008)
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries
Rune Kvale et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients
Rui Henrique et al.
CLINICAL CANCER RESEARCH (2007)
Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and Hypopharyngeal cancers
Rajesh P. Dikshit et al.
CANCER (2007)
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis
Susan Cottrell et al.
JOURNAL OF UROLOGY (2007)
Prostate-specific antigen levels as a predictor of lethal prostate cancer
Katja Fall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Role of nomograms for prostate cancer in 2007
Felix K. -H. Chun et al.
WORLD JOURNAL OF UROLOGY (2007)
Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy
Patrick J. Bastian et al.
EUROPEAN UROLOGY (2007)
Promoter hypermethylation of GSTPI, AR, and 14-3-3σ in serum of prostate cancer patients and its clinical relevance
Jochen Reibenwein et al.
PROSTATE (2007)
Hypermethylation of CpG island loci and hypomethylation of LINE-I and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features
N-Y Cho et al.
JOURNAL OF PATHOLOGY (2007)
Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007
Isabelle Meiers et al.
PATHOLOGY (2007)
Efficient DNA extraction from 25-year-old paraffin-embedded tissues: study of 365 samples
Anna Gillio-Tos et al.
PATHOLOGY (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
Roles and regulation of Wnt signaling and β-catenin in prostate cancer
Meletios Verras et al.
CANCER LETTERS (2006)
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
Andrew J. Stephenson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma
H Enokida et al.
CANCER (2006)
The emerging roles of DNA methylation in the clinical management of prostate cancer
Antoinette S. Perry et al.
ENDOCRINE-RELATED CANCER (2006)
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy
E Rosenbaum et al.
CLINICAL CANCER RESEARCH (2005)
Multigene methylation analysis for detection and staging of prostate cancer
H Enokida et al.
CLINICAL CANCER RESEARCH (2005)
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer
H Enokida et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower
IM Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy
PJ Bastian et al.
CLINICAL CANCER RESEARCH (2005)
Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci
PJ Bastian et al.
CLINICAL CANCER RESEARCH (2005)
Hypermethylation of CpG islands in primary and metastatic human prostate cancer
S Yegnasubramanian et al.
CANCER RESEARCH (2004)
Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia
GH Kang et al.
JOURNAL OF PATHOLOGY (2004)
Practice of opportunistic prostate-specific antigen screening in Italy: data from the Health Search database
G D'Ambrosio et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2004)
Prostate-specific antigen:: A review of the validation of the most commonly used cancer biomarker
J Hernández et al.
CANCER (2004)
Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma
Y Tokumaru et al.
CLINICAL CANCER RESEARCH (2004)
A quantitative promoter methylation profile of prostate cancer
C Jerónimo et al.
CLINICAL CANCER RESEARCH (2004)
Molecular biomarker in prostate cancer: The role of CpG island hypermethylation
PJ Bastian et al.
EUROPEAN UROLOGY (2004)
Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer
G Draisma et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
M Esteller
ONCOGENE (2002)
Estimate of population coverage with the prostate specific antigen (PSA) test to screen for prostate cancer in a metropolitan area of northern Italy
A Russo et al.
JOURNAL OF MEDICAL SCREENING (2002)
Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia
T Tsuchiya et al.
ONCOGENE (2000)